Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma (NMSG 15/05)
2005-002756-18Phase 3Completed
- Sponsor
- Nordic Myeloma Study Group
- Start
- Jul 2005
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in multiple myeloma (MM) comparing No consolidation (standard of care) with Velcade consolidation (2 arms). Primary endpoint: Event-free survival. Started Jul 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2005-002756-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002756-18.